Fitness Trends Prostate Cancer Therapeutics Market | Page 3

metastatic hormone-refractory prostate cancer (mHRPC) was approved by Scottish Medicines
Consortium (SMC) for restricted use within NHS Scotland, due to which Scotland has now
collaborated with health authorities in Northern Ireland, England and Wales. Thereby, reducing
potential disparities in care across the UK for this vulnerable group of patients.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1257
Key players operating in the prostate cancer therapeutics market include Johnson & Johnson,
Astella, Inc, Sanofi-Aventis, Bayer AG, AstraZeneca Plc, Pfizer Inc., Dendreon Corporation
(Sanpower Group Co. Ltd.), Ipsen Group, Tolmar Inc, Endo Pharmaceuticals, AbbVie, Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: [phone]
Email: [e-mail]